Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
176.55
-1.10 (-0.62%)
At close: Jun 26, 2026, 4:00 PM EDT
177.24
+0.69 (0.39%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Illumina Employees
Illumina had 10,080 employees as of December 28, 2025. The number of employees decreased by 290 or -2.80% compared to the previous year.
Employees
10,080
Change (1Y)
-290
Growth (1Y)
-2.80%
Revenue / Employee
$435,813
Profits / Employee
$84,623
Market Cap
26.71B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 28, 2025 | 10,080 | -290 | -2.80% |
| Dec 31, 2024 | 10,370 | -2,020 | -16.30% |
| Dec 31, 2023 | 12,390 | -970 | -7.26% |
| Dec 31, 2022 | 13,360 | 1,610 | 13.70% |
| Dec 31, 2021 | 11,750 | 2,400 | 25.67% |
| Dec 31, 2020 | 9,350 | 1,650 | 21.43% |
| Dec 29, 2019 | 7,700 | 400 | 5.48% |
| Dec 30, 2018 | 7,300 | 1,100 | 17.74% |
| Dec 31, 2017 | 6,200 | 700 | 12.73% |
| Dec 31, 2016 | 5,500 | 900 | 19.57% |
| Dec 31, 2015 | 4,600 | 900 | 24.32% |
| Dec 28, 2014 | 3,700 | 700 | 23.33% |
| Dec 29, 2013 | 3,000 | 800 | 36.36% |
| Dec 31, 2012 | 2,200 | -200 | -8.33% |
| Dec 30, 2012 | 2,400 | 300 | 14.29% |
| Dec 31, 2011 | 2,100 | 319 | 17.91% |
| Dec 31, 2010 | 1,781 | 245 | 15.95% |
| Dec 28, 2008 | 1,536 | 495 | 47.55% |
| Dec 30, 2007 | 1,041 | 445 | 74.66% |
| Dec 31, 2006 | 596 | 221 | 58.93% |
| Dec 31, 2005 | 375 | 97 | 34.89% |
| Dec 31, 2004 | 278 | 42 | 17.80% |
| Dec 28, 2003 | 236 | 3 | 1.29% |
| Dec 29, 2002 | 233 | 54 | 30.17% |
| Dec 30, 2001 | 179 | 74 | 70.48% |
| Dec 31, 2000 | 105 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IQVIA Holdings | 93,000 |
| Labcorp Holdings | 71,000 |
| Quest Diagnostics | 57,000 |
| ICON Public Limited Company | 40,100 |
| Mettler-Toledo International | 18,100 |
| Agilent Technologies | 18,100 |
| IDEXX Laboratories | 11,000 |
| Waters | 7,900 |
ILMN News
- 19 hours ago - Illumina resumed with a Market Perform at Bernstein - TheFly
- 2 days ago - Illumina price target raised to $145 from $122 at Barclays - TheFly
- 3 days ago - Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors - PRNewsWire
- 9 days ago - The Healthcare M&A Wave - Forbes
- 16 days ago - JPMorgan upgrades Illumina to Overweight after favorable customer survey - TheFly
- 16 days ago - Illumina upgraded to Overweight from Neutral at JPMorgan - TheFly
- 17 days ago - Illumina (ILMN): Bullish Structure Builds After Breakout - FXEmpire
- 18 days ago - Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution - PRNewsWire